SEC Form 4 · accession 0001493152-26-042512
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amit Kumar
Officer — Chief Executive Officer · Director
Period of report
Sep 10, 2026
Accepted (ET)
Sep 14, 2026 · 9:45 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000715446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 10, 2026 | P | 3,000 | $2.75 | A | 665,000 | D |
Table II — derivative securities
No Table II lines on this filing.